ABSTRACT. Autoantibodies from a patient with rheumatoid arthritis recognized an antigen localized in the Golgi complex of various cells tested. The autoantibodies were used as a probe for screening rat NRKCDNA library, resulting in identification of an ll kbp CDNA. The CDNA contained an open reading frame which encodes a 3,187-residue protein with a calculated mass of 364 kDa. The predicted protein, GCP364(for a Golgi complex-associated protein of 364 kDa), was found to have no NH2-terminal signal sequence but a single hydrophobic domain at the COOH terminus and characteristically contain manycoiled-coil domains with various sizes throughout the entire sequence. The identity of GCP364with the autoantigen was confirmed by immunofluorescence and immunoblot analysis with the autoantibodies and anti-recombinant GCP364produced in rabbits and by transfection/expression experiments. Search for the protein sequence data base revealed that GCP364 has 75% identity in amino acid sequence with human GCP372/giantin, indicating that it is a rat homolog of the latter. Immunogold electron microscopy showed that GCP364was not detected on coated vesicles derived from the Golgi membrane, suggesting no involvement in the formation of transport vesicles. Whencells were perforated and incubated with anti-GCP364 serum, the Golgi complex localized at perinuclear regions was dispersed into fragment-like structures as observed in nocodazole-treated cells. Taken together, these results suggest that GCP364is anchored to the membraneby the COOH-terminal hydrophobic domain and has an extremely long cytoplasmic domain with coiled-coil structures, which may be involved in the formation and/or maintenance of the characteristic Golgi structure.
Protein transport through these Golgi subcompartments is believed to be mediated by small vesicles. Recent studies have identified a numberof cytosolic and * To whom correspondence and reprint requests should be addressed.
Abbreviations: ARF, ADP-ribosylation factor; COP, coat protein complex (coatomer); ER, endoplasmic reticulum; GCP, Golgi complex-associated protein; GST, glutathione S-transferase; HRP, horseradish peroxidase; Man II, a-mannosidase II; PNS, post-nuclear supernatant; RA, rheumatoid arthritis. The nucleotide sequence of GCP364has been deposited in the DDBJ/EMBL/GenBank Data Libraries under the accession number D25543. membraneproteins involved in the vesicular transport (33, 34) . These include coat protein complex (coatomer, COP I) and ADP-ribosylation factor (ARF) required for budding and formation of Golgi-derived transport vesicles, and N-ethylmaleimide-sensitive fusion protein (NSF) and soluble NSF attachment proteins (SNAP) and SNAP receptors (SNARE) involved in the vesicle fusion. Available evidence indicates that the vesicular transport system functions not only in delivery of proteins to their final destinations but also in maintenance of the Golgi structure. Brefeldin A, initially found as a potent inhibitor of secretion (ll, 23) , is known to block the budding/formation of transport vesicles by inhibiting a GDP/GTP exchange of ARFwhich is essential for the attachment ofARFand COPI onto the Golgi membrane (6, 16, 31) . The inhibition of vesicular transport is accompanied by redistribution of resident Golgi components to the ER, resulting in disassembly of the Golgi stack (ll, 12, 21) . The Golgi structure is reformed immediately after removal of the drug. These observations suggest that the Golgi structure is maintained by vesicu-lar transport-dependent supply of the resident Golgi components and their balanced recycling between the ER and the Golgi. Despite these findings, the mechanism for vesicular transport alone maynot be sufficient to explain the formation of the unique Golgi structure with the ordered stacking, close apposition and constant spacing of stacked cisternae. There must be other components, in addition to those involved in the vesicular transport, which would be responsible for the formation or structural arrangement of the subcompartments in the Golgi complex. Many investigators have attempted to identify such components by preparing antibodies to the Golgi complexor by autoantibodies in sera from patients with autoimmune diseases. Golgi-associated proteins including giantin (19), p210 (27) and GM130 (26) were identified by antibodies directed against the purified Golgi complex, while a 79-kDa protein (17), golgin-95 and gol- gin-160 (8), p210 (32) , GCP230 (13), golgin-245/p230
(7, 9) and GCP372 (41) were characterized by the autoantibodies. Most of these proteins are peripheral proteins loosely (7-9, 13, 27, 32) or tightly (26) associated with the Golgi membrane, while giantin and GCP372
are integral membraneproteins (1 , 41) . A structural similarity of the latter two indicates that GCP372is an isoform of giantin (37, 41) . In this study we have identified a 364-kDa protein (GCP364) associated with the Golgi complex which was recognized by autoantibodies from a patient with rheumatoid arthritis (RA) and isolated its CDNA clones from a rat NRKCDNAlibrary. The primary and secondary structures predicted by the CDNA sequence and coiled-coil probability, respectively, indicate that GCP364 is a member of the GCP372/giantin family.
MATERIALS AND METHODS
Materials. A serum containing anti-Golgi autoantibodies was obtained from a Chinese patient with rheumatoid arthritis (RA). Cy2-conjugated goat anti-human IgG was from Biological Detection Systems Inc. (Pittsburgh, PA); horseradish peroxidase (HRP)-conjugated goat anti-human IgG was from Bio-Rad (Richmond, CA); rhodamine-or HRP-conjugated goat anti-rabbit IgG was from DAKOJapan (Tokyo); monoclonal anti-rat a-mannosidase II (Man II) and goat anti-a-tubulin antiserum were from Funakoshi (Tokyo). Rabbit antirat Man II was supplied by Dr. K. Moremen (University of Georgia). Anti-^-COP antibodies were raised in rabbits (38) .
ECLWestern blotting detection kit was obtained from Amersham Japan (Tokyo). Various DNA-modifying enzymes and restriction endonucleases were purchased from ToyoboBiochemicals (Osaka), Takara Shuzo (Kyoto) and Nippon Gene (Toyama, Japan).
Cell Culture. NRK(rat kidney), COS-1 (monkey kidney) and HepG2(human hepatoma) cells were cultured as described previously (41) . Isolation and Sequencing of CDNAClones. A poly(A)+ RNAfraction prepared from NRKcells was used for construction of the CDNAlibrary in^ZAPII bacteriophage, which was subjected to screening with the autoantibodies as described previously (24). Screening of 2 x 106 independent clones with the autoantibodies yielded 10 positive clones. After plaque purification, the cDNAs were subcloned into the pbluescriptSK" plasmid vector by auto-excision process and analyzed by restriction endonuclease mapping. A 5' 900-bp fragment of the CDNAclone which had the longest insert (6.1 kbp) was used as a probe for further screening of the library by the plaque hybridization method (30) , and 15 positive clones were obtained. All the positive clones were sequenced by the dideoxynucleotide chain termination method (35) Hindlll fragment (1.6 kb) of AGM24(see Fig. 2 ).
Construction, Transfection and Expression of the Complete GCP364 CDNA. A CDNAcovering the entire coding region of GCP364was constructed from the three CDNA clones AGM24, AGP25 and AGP1326 (see Fig. 2 ). An internal Production of Anti-recombinant GCP364 Antibodies. The three CDNAfragments F-l, F-2 and F-3 (see Fig. 2 ) were prepared by digestion of the indicated CDNAclones with appropriate restriction endonucleases; F-l was an EcoRIStuI fragment derived from AGP25 (1293 ( -1923 nucleotide number); F-2, an EcoRI-EcoRV fragment from AGP2808 (4356-5729); and F-3, an EcoRV-Hindlll fragment from AGM24(5730-7915). Each fragment was inserted into an appropriate site of PGEX-2Tvector for production of fusion proteins with glutathione S-transferase (GST). Expression and purification of the GST-fusion proteins were performed according to the method of Smith and Johnson (40) . Anti-recombinant GCP364(rGCP364) antibodies were raised in rabbits by injecting a mixture of the three recombinant proteins (200 ftg each protein/injection/rabbit) several times every two weeks. Antibodies against GSTin the fusion pro-teins were removed by adsorption with GST-coupled Toyopearl 650. Immunocytochemistry.
Immunofluorescence microscopy was carried out as described before (41) . Briefly, cells were fixed with 4% paraformaldehyde, permeabilized with 0. 1% saponin, and incubated with the indicated primary antibodies, followed by incubation with the indicated rhodamine-or Cy2-conjugated secondary antibodies. For immunoelectron microscopy, cells were fixed with the periodate-rysine-paraformaldehyde fixative for 2 h at room temperature. After being permeabilized as above, cells were incubated at roomtemperature with the autoantibodies and then with HRP-conjugated anti-human IgG antibodies. The peroxidase reaction was carried out at roomtemperature for 15 min in a substrate mediumcontaining diaminobenzidiine (0.5 mg/ml) and 0.01% H2O2. The cells were processed for electron microscopy as described previously (1 1 (41) .
Immunoblotting. This was performed as described previously (14). Proteins were separated by SDS-PAGE (5% gel) and transferred to an Immobilon PVDFmembrane. The membrane was incubated with the autoantibodies serum at dilution of 1:500 or with anti-rGCP364 serum at dilution of 1 : 1000. HRP-conjugated anti-human IgG or anti-rabbit IgG antibodies at dilution of 1 :2000 was used as secondary antibodies, and the membrane was processed for enhanced chemiluminescence (ECL kit).
Cell Fractionation and MembraneExtraction. Cells were homogenized in a solution containing 0.25 Msucrose, 10 mM Tris-HCl (pH 7.5) and 2 mMEDTA (homogenizing buffer) in a nitrogen bombardment apparatus (Parr Instrument Co., IL), and the homogenate was centrifuged at 1,000g for 10 min. The resultant supernatant was used as a postnuclear supernatant (PNS). Equal amounts of the PNSwere centrifuged at 105,000 g for 1 h to obtain membrane pellets and supernatant (cytosol). The membranes were resuspended in the homogenizing buffer containing either 0.1 MNa2CO3, 1% Triton X-100 or 1% sodium deoxycholate. After being incubated on ice for 30 min, the suspensions were centrifuged at 105,000 g for 30 min to obtain supernatants and membrane pellets.
In Vitro Accumulation of Golgi-derived Transport Vesicles. Golgi membranes (29) and cytosol (1) were prepared from rat liver and brain, respectively, and used for in vitro budding and formation of Golgi vesicles (31) . The Golgi membranes (200 fig protein/ml) and cytosol (2.3 mg protein/ml) were incubated at 37°C for 30 min in 0.2 ml of 0.2 Msucrose containing 25 mMHepes-KOH (pH7.2), 25 mMKC1, 2.5 mM magnesiumacetate and the ATP-regenerating system (0.25 mMATP, 10 /^g/ml ofcreatine kinase and 2.5 mMcreatine phosphate) in the absence or presence of 20^M GTPfS. The membraneswere pelleted, fixed and cryosectioned for immunogold labeling as described above. Other Treatments of Cells. NRKcells were perforated as described previously (39) . The perforated cells were incubated at 37°C for 1 h with anti-rGCP642 serum or non-immune serum (10%) in 25 mMHepes-KOH (pH 7.2), 115 mM KC1 and 2.5 mMmagnesium acetate (medium A) containing rat brain cytosol (5 mg/ml) and the ATP-regenerating system (0.5 mM ATP, 5 mMcreatine phosphate and 50^g/ml of creatine kinase). For depolymerization of microtubules, intact cells were incubated at 37°C for 1 h with 50pM nocodazole in the Dulbecco's minimumessential medium. ComputerAnalysis ofcDNA andProtein. CDNAand protein sequences were analyzed by the GENETX genetic information processing software (Software Development Co., Tokyo) and FASTAprogram at the DNAData Bank of Japan (Mishima, Japan). Coiled-coil graphs were made from data generated by COILS (ver. 2. 1) algorithm of Swiss Cancer Research Institute (22). The MTDIKmatrix and a window size of 28 residues were used.
RESULTS
Identification of a Golgi Antigen with Autoantibodies. A serum obtained from an RA patient was used for indirect immunofluorescence staining of rat NRKcells. A heavy staining with immunofluorescence was observed at perinuclear regions (Fig. 1A, a) , where the Golgi marker a-mannosidase II (Manll) was colocalized whenthe cells were double-stained with anti-Manll (Fig. 1A, b) . The intracellular localization of the antigen was examined in more detail by immunoelectron microscopy. A positive reaction of the immunoperoxidase was detected at the Golgi complex with a characteristic stack structure (Fig. 1A, c ). These observations indicate that the antigen recognized by the autoantibodies is localized at the Golgi complex. The autoantibodies were found to cross-react with various cells derived from other species including mouse, hamster, monkey, chicken as well as human(data not shown). Immunoblotting experimentsshowedthat the autoantibodies recognized a protein with an apparent molecular mass of at least 300 kDa in all cells examined, of which results with NRK,COS-1 and HepG2cells were shown in Fig. IB . CDNACloning of the Golgi Antigen. We then isolated CDNAclones for the Golgi antigen from the NRK CDNAlibrary. Screening of the library with the autoantibodies and subsequent screening by the plaque hybridization method yielded seven major CDNA clones with inserts longer than 3 kbp, which overlapped from each other and together spanned a stretch of about 10 kbp of DNA (Fig. 2 ). Total and poly(A)+ RNAprepared from the NRKcells were blotted and probed with 32P-labeled CDNAfragments, which identified an RNAcomponent of about llkb (Fig. 3) . The value of llkb in the mRNAis in good agreement with that determined for the complete CDNAof the Golgi antigen. Predicted Structure of the Golgi Antigen GCP364.
The seven CDNA inserts were sequenced from multiple restriction sites and on both DNAstrands. The combined nucleotide sequence (10, 172 nucleotides) includes the 5' noncoding region (291 nucleotides), the coding region (9,561 nucleotides) and the 3' noncoding region (320 nucleotides).
The open reading frame encodes a protein of 3,187 amino acid residues with a calculated mass of 364 kDa (Fig. 4) . Here we designate this protein GCP364. The predicted amino acid sequence of GCP364contains no hydrophobic domain at the NH2 terminus which serves as the translocation signal across the ER membrane, but has a single hydrophobic domain at the COOHterminus that could participate in membrane localization. The leucine zipper motif Leu-X6-Leu-X6-Leu-X6-Leu and other heptad repeats are frequently seen in the entire sequence, predicting the formation of coiled-coil structures (22). The deduced amino acid sequence of GCP364was comparedwith the knownprotein sequences so far reported, demonstrating some similarity (18-22% identity) with many filamentous proteins containing coiledcoil domains such as myosins, desmin and desmoplakin. The most striking similarity was found in human GCP372/giantin (37, 41) , which had 77.7% (nucleotide sequence) and 75% (amino acid sequence) identity with those of GCP364. The coiled-coil probability of GCP364 was compared with that of GCP372/giantin (Fig. 5) . Almost the entire sequence of GCP364 is occupied by coiled-coil domains, which are interrupted by relatively long non-coil domains with more than 50 amino acids at the both termini and at three sites between them (indicated by thick bars in Fig. 5A ), although there are manyother short interruptions. These features in the secondary structure are conserved in the human GCP372/giantin. The four major coiled-coil domains share 69-81% identity in the amino acid sequence between GCP364 and GCP372/giantin ( NH2-and COOH-terminal non-coil domains also show a high similarity with 62% and 82% identity, respectively, and the putative transmembrane domain at the COOHterminus (Fig. 4) has 95% identity between the two proteins. In contrast, the internal non-coil segments have a relatively low similarity with 38-45% identity.
The Identity of GCP364 with the Golgi Autoantigen. Antibodies for GCP364were raised in rabbits by injecting recombinant fusion proteins derived from the three coding regions F-l, F-2 and F-3 of the GCP364
CDNA (see Fig. 2 ). The resulting antibodies (antirGCP364) were used for indirect immunofluorescence microscopy and immunoblotting. Double staining of NRK cells with the autoantibodies and the antirGCP364 showed essentially the same profile, demonstrating that both antibodies recognized the same antigen localized at the perinuclear regions (Fig. 6A) . Immunoelectron microscopy confirmed that the immunoperoxidase with the anti-GCP364 antibodies specifically stained the Golgi complex (data not shown), as observed with the autoantibodies (Fig. 1A, C) . In addition, immunoblot analysis of cell lysates showed that the anti-rGCP364 reacted with an approximately 360-kDa protein in NRKcells and also cross-reacted with that of COS-1 and HepG2 cells (Fig. 6B) . The apparent molecular mass of the protein corresponds to that obtained with the autoantibodies (Fig. IB) and is reasonably consistent with those calculated from the predicted sequences (364-372 kDa). Fig. 5 . Similarity of the primary and secondary structures between rat GCP364 and human giantin. (A) Coiled-coil probabilities of GCP364 and giantin. The probability profiles were made from data generated by COILS(ver. 2. 1) algorithm. The MTDIKmatrix and a window size of 28 residues were used. Three major (more than 50 residues) and seven minor (less than 50 residues) non-coil domains are indicated by thick bars and asterisks, respectively. (B) Domain-dependent similarities in the primary structure of the two proteins. The similarities are expressed as % identity in the sequences of individual domains which were determined by the coiled-coil probability shown in (A); four overall coiled-coil domains (open boxes), three major internal non-coil domains (hatched boxes) and the NH2-and COOH-terminal non-coil domains (dotted boxes).
Weexamined an interaction of GCP364with membranes. Whena PNSfraction of NRKcells in the homogenizing buffer was separated by centrifugation into membranes and cytosol, GCP364was completely sedimented with the membranes (Fig. 8, lanes 1 and 2) . No GCP364was released from the membranesby treatment with 1 MNaCl. The membraneswere then treated with either 0.1 M sodium carbonate (pH ll), 1% Triton X-100 or 1% sodium deoxycholate. GCP364was not extracted from the membranesby the sodium carbonate treatment (Fig. 8, lanes 3 and 4) , and partially extracted with Triton X-100 (lanes 5 and 6). The complete extraction of the protein was carried out by the deoxycholate treatment (lanes 7 and 8). The results indicate that GCP364is an integral membraneprotein, possibly anchoring to the membranes by the COOH-terminal hydrophobic domain. No Involvement of GCP364in the Formation of Coated Vesicles. The formation of COPI-coated vesicles is characterized by assembly of ARFand coatomer from the cytosol to the Golgi membrane (31, 33) . However, little information is available for membraneproteins involved in the interaction with these coat proteins. Weexamined a possible involvement of GCP364 in the formation of the coated vesicles, which were accumulated in vitro by incubating the Golgi membranes in the presence of GTP/-S (7). Localization of GCP364 was detected by immunogold labeling and compared with that of^8-COP, a subunit of the coatomer. The coated vesicles were labeled with immunogold particles for /3-COP (Fig. 9B ), but not significantly labeled with those for GCP364, which were detected on other membrane components (Fig. 9A ). These observations suggest that GCP364 is not directly involved in the budding and formation of the Golgi-derived coated vesicles. Effect of Anti-rGCP364 Antibodies on the Golgi Structure. A possible function of GCP364was examined by incubation of cells with anti-rGCP364 antibodies after cells were perforated (39) . The perinuclear localization and characteristic morphology of the Golgi complex were found to be maintained in the perforated cells (Fig. 10A) and not so significantly altered even after incubation of the cells with non-immune serum at 37°C for 1 h (Fig. 10B) . In contrast, when cells were incubated with anti-rGCP364 antiserum, the Golgi complex marked with Manll was disassembled into small fragment-like structures which were dispersed in the cytoplasm (Fig. IOC) . These changes of the Golgi structure were quite similar with those in cells treated with the microtubule-depolymerizing drug nocodazole (Fig.   10D ). However, the network of microtubules was still almost normally maintained in the anti-rGCP364-treated cells (Fig. 10E) , in contrast to the complete depolymerization of microtubules in the nocodazole-treated cells (Fig. 10F) . These results suggest that GCP364 may be involved in the maintenance of the characteristic Golgi structure.
DISCUSSION
Autoantibodies which recognize antigens in the Golgi complex are occasionally found in sera from patients with autoimmune diseases including RA (17, 37, 41), Sjogren's syndrome (7) and systemic lupus erythematosus (8, 9). Although the clinical relevance of the production of such autoantibodies is uncertain, these antibodies could provide useful tools for structural analysis of the Golgi complex. In addition to production of monoclonal and polyclonal antibodies to Golgi membranes anti-Golgi autoantibodies is a convenient way to identify proteins associated with the Golgi complex (7-9, 17, 37, 41) . It is commonly observed that Golgi antigens so far identified are cytoplasmically disposed peripheral and integral membrane proteins.
In the present study we have isolated CDNAclones for a Golgi-associated protein recognized by autoantibodies from a patient with RA, for which the NRK CDNA library was used since the NRKcells were most intensely stained with the autoantibodies-coupled immunofluorescence. Although we could not obtain a single CDNA clone which should cover all the coding region, overlapping inserts of the obtained CDNAclones demonstrated that the combined sequence has ll kbp of DNA, which encodes a 3,187-residue protein with a calculated mass of 364 kDa (GCP364). The fact that this is the complete CDNAfor the antigen recognized by the auto-antibodies was confirmed by the following findings. 1) The presence of the mRNA with the same size (1 1 kb) was identified by the Northern blotting. 2) AntirGCP364 antibodies recognized the same antigen as that detected by the autoantibodies.
3) The product expressed by transfection with the CDNAwas recognized by the autoantibodies as well as the anti-rGCP364 and had the same molecular mass as that of the endogenous antigen.
Hydropathy plot analysis of the predicted sequence showed that GCP364has no signal sequence at the NH2 terminus but a single hydrophobic domain at the COOHterminus, indicating that the protein is cytoplasmically disposed and anchored to the Golgi membrane by the COOH-terminal hydrophobic domain. No extraction of GCP364from the membrane with sodium carbonate treatment confirmed that it is an integral membrane protein (10). The membrane topology of GCP364 with extension to the cytoplasm was further supported by the fact that when isolated intact Golgi membranes were treated with trypsin/chymotrypsin, the protein was no longer detected in the membraneswhile the lumenal membraneprotein Manll remained almost intact (Fujiwara, T. and Ikehara, Y.; unpublished results as a^400-kDa Golgi-associated protein which was recognized by a monoclonal antibody directed to Caco-2 Golgi membranes (19) and also by autoantibodies from a patient with RA (37) . The primary structure of giantin (376 kDa) was predicted by cloning and sequencing of its CDNA (37) . GCP372 we independently identified with autoantibodies from a patient with RAis an isoform of giantin, lacking the NH2-terminal 34 amino acid residues (41) . The complete identity in the other sequence indicates that the two proteins are produced by alternative splicing of transcripts from the same gene. Since we have isolated both the giantin and GCP372 CDNAclones from the same HepG2 CDNAlibrary, it is likely that the two proteins are actually expressed in cells. Rat GCP364has a similar NH2-terminal extension as that of giantin, indicating that GCP364 is a homolog of giantin in the strict sense, although we cannot rule out a possible existence in rat of another form corresponding to GCP372. The difference in molecular mass between rat GCP364 and human GCP372/giantin is due to one major and two minor deletions which are found between positions 220 and 580 from the NH2ter-minus. The almost entire sequences of GCP364 and GCP372 /giantin are occupied by coiled-coil structures, which are divided into four major domains by three relatively long gaps interrupting the coiled-coil (Fig. 5) . The sequence similarity of the rat and humanproteins is much higher in the coiled-coil domains (69-81%) than in the gaps (38-41%) , suggesting that these coiled-coil domains play an important role in structure and function of the proteins. The evidence that a long charge-rich ahelical domain is commonly found in autoantigens (5) suggests that the conserved coiled-coil domainsserve as antigenic epitopes for producing the autoantibodies in patients with autoimmune diseases. In fact, the autoantibodies cross-react well with the corresponding antigens in cells from various species including mammalian and avian (41) .
The coiled-coil domain is now considered, in addition to as a DNAbinding motif, as a mediator of dior oligomerization by its hydrophobic interaction, as shown in HIV envelope proteins (42) and influenza hemagglutinin (3). It was also reported that coiled-coil domains are involved in trimerization of cartilage matrix protein subunits which is stabilized by intermolecular disulfide bonding of cysteine residues in the coiled-coil domains (15). As it was suggested that giantin exists as a disulfide-linked homodimer (19), the coiled-coil domains of GCP364may play a role in the formation of homoor hetero-oligomers. Other Golgi-associated peripheral proteins such as golgin-245/p230 (7, 9), golgin-95 and golgin-160 (8), pi15 (36) and GM130 (26) Nakamura et al. (26) . On the other hand, the gap domains between the coiled-coils could contribute to protein structure and function by creating a fixed bend or a flexible hinge (28). Although the amino acid sequences in the gaps show low similarities, the numbers and positions of the gaps are well conserved in the rat GCP364 and human GCP372/giantin. The biological function of GCP364remains to be clarified. The preferential localization of GCP364 and GCP372 (41) Recently it has been reported that /3-spectrin (2) and ankyrin (4) homologs are associated with the Golgi complex and may act to organize micro-domains within the Golgi membrane by linking them to cytoskeletons. In addition, since microtubule-depolymerizing agents such as nocodazole and colchicine cause fragmentation and dispersion of the Golgi complex, interaction of the Golgi complex with microtubule network is important to maintain the appropriate Golgi structure (18). Under the conditions which stabilize the microtubule and actin filament networks, giantin (19) and GCP364 (not shown) are not extracted with Triton X-100 and keep the association with an apparently preserved Golgi structure, in contrast to easy extraction of the lumenal membrane proteins galactosyl transferase and Manll. Thus, these observations suggest that the giantin family proteins mayfunction as a scaffold protein of the Golgi complex, which stacks the Golgi cisternae and stabilizes the organelle structure. This maybe supported by the present finding that treatment of cells with antirGCP364antibodies causes disruption of the Golgi complex. Further studies are required to obtain moredirect evidence for the interaction of GCP364with the cytoskeletons. It is also of interest to know whether GCP364 interacts with other Golgi-associated proteins having the long coiled-coil domains.
